{"transactions":[{"id":727615,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 22, 2022 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.7132,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":727614,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5.0157,"value":125392.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":727613,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T15:11:33.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":0.7132,"value":17830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001214659-26-007677","document":"marketforms-73450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007677/marketforms-73450.xml","form_type":"4"}},{"id":739795,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T15:43:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007398","document":"marketforms-73384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465926007398/marketforms-73384.xml","form_type":"4"}},{"id":751705,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:22:33.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":67500,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001643127-26-000002","document":"form4-06032026_090627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000164312726000002/form4-06032026_090627.xml","form_type":"4"}},{"id":1009558,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-03T21:32:02.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date."}],"balance_after":450000,"derivative":{"exercise_price":4.58,"expiration_date":"2035-08-10","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001643127-25-000006","document":"form4-11032025_091158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000164312725000006/form4-11032025_091158.xml","form_type":"4"}},{"id":1113320,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T17:59:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009123","document":"marketforms-69482.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465925009123/marketforms-69482.xml","form_type":"4"}},{"id":1472012,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-06-21T17:50:44.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.5,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001214659-24-011218","document":"marketforms-66326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465924011218/marketforms-66326.xml","form_type":"4"}},{"id":1845193,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-06-23T16:28:38.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.02,"exercise_date":"2024-06-21","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-23-008797","document":"marketforms-61961.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465923008797/marketforms-61961.xml","form_type":"4"}},{"id":2222037,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-06-24T20:22:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 22, 2023, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.7132,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-22-008288","document":"marketforms-56517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465922008288/marketforms-56517.xml","form_type":"4"}},{"id":2663788,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-17T22:50:51.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.04,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-21-006716","document":"marketforms-53149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465921006716/marketforms-53149.xml","form_type":"4"}},{"id":2789192,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-15T21:10:53.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 11, 2022."}],"balance_after":28500,"derivative":{"exercise_price":5.3,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001214659-21-003154","document":"marketforms-51884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643127/000121465921003154/marketforms-51884.xml","form_type":"4"}},{"id":3229615,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-04T17:48:48.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":1333,"price":7.75,"value":10330.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 4,333 restricted stock units (\"RSUs\") on March 2, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reporting person's total beneficial ownership has been adjusted to reflect that no shares were awarded pursuant to the performance-based RSU award granted on February 23, 2017.  The reporting person had previously reported beneficial ownership of 7,500 shares pursuant to the RSU award, which represented the target number of shares that could have been delivered based on the achievement of certain relative total stockholder return targets over a three year performance period, which were not met, and which target share amount was previously reported on a Form 4 filed on February 27, 2017."}],"balance_after":73044,"source":{"system":"sec-edgar","filing":"0001104659-20-029288","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920029288/a4.xml","form_type":"4"}},{"id":3250878,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-25T16:46:01.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":1155,"price":8.84,"value":10210.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,333 restricted stock units on February 25, 2020."}],"balance_after":81877,"source":{"system":"sec-edgar","filing":"0000792977-20-000018","document":"wf-form4_158266714405265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000018/wf-form4_158266714405265.xml","form_type":"4"}},{"id":3250877,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-25T16:46:01.000Z","date":"2020-02-23","kind":"tax_withholding","acquired":false,"shares":867,"price":9.5,"value":8236.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,501 restricted stock units on February 23, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reporting person's total beneficial ownership reflects the purchase of 2,500 shares through an Employee Stock Purchase Plan on November 30, 2019."}],"balance_after":83032,"source":{"system":"sec-edgar","filing":"0000792977-20-000018","document":"wf-form4_158266714405265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000018/wf-form4_158266714405265.xml","form_type":"4"}},{"id":3509507,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-29T16:27:37.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":10000,"price":9.91,"value":99100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $9.85 to $9.96, inclusive. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price."}],"balance_after":81399,"source":{"system":"sec-edgar","filing":"0000792977-19-000113","document":"wf-form4_155916164243275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000113/wf-form4_155916164243275.xml","form_type":"4"}},{"id":3616342,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-05T18:09:11.000Z","date":"2019-03-02","kind":"tax_withholding","acquired":false,"shares":1247,"price":14.76,"value":18405.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 4,332 restricted stock units on March 2, 2019."}],"balance_after":71399,"source":{"system":"sec-edgar","filing":"0000792977-19-000047","document":"wf-form4_155182733771361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000047/wf-form4_155182733771361.xml","form_type":"4"}},{"id":3616341,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-05T18:09:11.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":960,"price":14.76,"value":14169.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,001 restricted stock units on March 1, 2019."}],"balance_after":72646,"source":{"system":"sec-edgar","filing":"0000792977-19-000047","document":"wf-form4_155182733771361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000047/wf-form4_155182733771361.xml","form_type":"4"}},{"id":3630339,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-27T18:30:26.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":25000,"derivative":{"exercise_price":15.51,"expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000792977-19-000031","document":"wf-form4_155131021117253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000031/wf-form4_155131021117253.xml","form_type":"4"}},{"id":3630338,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-27T18:30:26.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending February 25, 2022 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":73606,"source":{"system":"sec-edgar","filing":"0000792977-19-000031","document":"wf-form4_155131021117253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000031/wf-form4_155131021117253.xml","form_type":"4"}},{"id":3630337,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-27T18:30:26.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the \"Plan\") that will vest in three equal annual installments with the first installment vesting on February 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":58606,"source":{"system":"sec-edgar","filing":"0000792977-19-000031","document":"wf-form4_155131021117253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000031/wf-form4_155131021117253.xml","form_type":"4"}},{"id":3634184,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-26T17:48:07.000Z","date":"2019-02-23","kind":"tax_withholding","acquired":false,"shares":869,"price":15.51,"value":13478.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,500 restricted stock units on February 23, 2019."}],"balance_after":48606,"source":{"system":"sec-edgar","filing":"0000792977-19-000024","document":"wf-form4_155122127416444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000024/wf-form4_155122127416444.xml","form_type":"4"}},{"id":3877346,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-03T16:03:03.000Z","date":"2018-07-02","kind":"tax_withholding","acquired":false,"shares":2161,"price":19.85,"value":42895.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 7,335 restricted stock units (\"RSUs\") on June 1, 2018. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. (the \"Issuer\"), the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until July 2, 2018, at which time 2,161 shares were withheld to satisfy the reporting person's applicable tax obligations."}],"balance_after":49475,"source":{"system":"sec-edgar","filing":"0000792977-18-000047","document":"wf-form4_153064816548719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000047/wf-form4_153064816548719.xml","form_type":"4"}},{"id":4012806,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-06T19:23:08.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":22000,"derivative":{"exercise_price":21,"expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001179110-18-003694","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003694/edgar.xml","form_type":"4"}},{"id":4012805,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CMO"}}],"security":"Common Stock","published_at":"2018-03-06T19:23:08.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":1700,"price":21,"value":35700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,499 RSUs on February 23, 2018 and 3,000 RSUs on March 1, 2018. Due to the black-out policies implemented by the Issuer, the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until March 2, 2018, at which time an aggregate of 1,700 shares were withheld to satisfy the reporting person's applicable tax obligations."}],"balance_after":51636,"source":{"system":"sec-edgar","filing":"0001179110-18-003694","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003694/edgar.xml","form_type":"4"}},{"id":4012804,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CMO"}}],"security":"Common Stock","published_at":"2018-03-06T19:23:08.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending March 1, 2021 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered  pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":53336,"source":{"system":"sec-edgar","filing":"0001179110-18-003694","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003694/edgar.xml","form_type":"4"}},{"id":4012803,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CMO"}}],"security":"Common Stock","published_at":"2018-03-06T19:23:08.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":13000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended and Restated 2007 Equity Incentive Plan (as amended the \"Plan\") and will vest in three equal annual installments with the first installment vesting on March 2, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":41336,"source":{"system":"sec-edgar","filing":"0001179110-18-003694","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911018003694/edgar.xml","form_type":"4"}},{"id":4257423,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-07-14T16:26:50.000Z","date":"2017-07-13","kind":"sale","acquired":false,"shares":4938,"price":20,"value":98760.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016."}],"balance_after":28336,"source":{"system":"sec-edgar","filing":"0001179110-17-010382","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017010382/edgar.xml","form_type":"4"}},{"id":4294382,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-06-05T08:42:44.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":2395,"price":17.9,"value":42870.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 7,333 restricted stock units on June 1, 2017."}],"balance_after":33274,"source":{"system":"sec-edgar","filing":"0001179110-17-008492","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017008492/edgar.xml","form_type":"4"}},{"id":4294381,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-06-05T08:42:44.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":1108,"price":22.85,"value":25317.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,999 restricted stock units on March 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's Form 4 filed on May 2, 2017 did not take into account the shares withheld on March 1, 2017, and therefore the amount reported in Column 5 on such Form 4 was overstated by 1,108 shares."}],"balance_after":35669,"source":{"system":"sec-edgar","filing":"0001179110-17-008492","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017008492/edgar.xml","form_type":"4"}},{"id":4339195,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-05-02T17:07:39.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":1891,"price":24.45,"value":46234.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016."}],"balance_after":36777,"source":{"system":"sec-edgar","filing":"0001179110-17-006402","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017006402/edgar.xml","form_type":"4"}},{"id":4423058,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-27T18:58:30.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter."}],"balance_after":20000,"derivative":{"exercise_price":23.75,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-17-003320","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003320/edgar.xml","form_type":"4"}},{"id":4423057,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-02-27T18:58:30.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending December 31, 2019, subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered  pursuant to the award (\"Target Award\"); however, the amount that vests could range from zero to 150% of the Target Award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":38668,"source":{"system":"sec-edgar","filing":"0001179110-17-003320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003320/edgar.xml","form_type":"4"}},{"id":4423056,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2017-02-27T18:58:30.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (as amended the \"Plan\") and will vest in three equal annual installments with the first installment vesting on February 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":31168,"source":{"system":"sec-edgar","filing":"0001179110-17-003320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017003320/edgar.xml","form_type":"4"}},{"id":4577129,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":35649,"kind":"person","name":"Krop Julie","position":1,"cik":"0001643127","reported_name":"Krop Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical & Regulatory, CMO"}}],"security":"Common Stock","published_at":"2016-10-20T16:07:23.000Z","date":"2016-10-20","kind":"sale","acquired":false,"shares":4938,"price":24.8,"value":122462.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016."}],"balance_after":23668,"source":{"system":"sec-edgar","filing":"0001179110-16-030835","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911016030835/edgar.xml","form_type":"4"}}]}